Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 9/20 | 0.62 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.62 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.62 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.57 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.57 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.51 |
| ▸ | PRKCG | P05129 | 1/20 | 0.51 |
| ▸ | PRKCB | P05771 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.51 |
| ▸ | PRKCH | P24723 | 1/20 | 0.51 |
| ▸ | PRKCI | P41743 | 1/20 | 0.51 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.51 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.51 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.51 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.51 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15158747 | 1.00 | LPAR1 (0.62) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL19829619 | 1.00 | LPAR1 (0.62) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL16303701 | 1.00 | LPAR1 (0.62) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL13659941 | 1.00 | LPAR1 (0.62) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL4294185 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL8636551 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL7563995 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL4879843 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL303128 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 | |
| SCHEMBL4204833 | 0.94 | LPAR1 (0.68) | LPAR1LPAR3LPAR2LPAR6LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9814777-B2 | Targeting lipids | ARBUTUS BIOPHARMA CORPORATION (CA) | 2017-11-14 | — | — | US | disclosed |
| EP-3156077-A1 | TARGETING LIPIDS | Arbutus Biopharma Corporation (CA) | 2017-04-19 | — | — | EP | disclosed |
| EP-2231195-B1 | TARGETING LIPIDS | ARBUTUS BIOPHARMA CORP (CA) | 2017-03-29 | — | — | EP | disclosed |
| US-20160376591-A1 | iRNA AGENTS WITH BIOCLEAVABLE TETHERS | BANK OF AMERICA, N.A. | 2016-12-29 | — | — | US | disclosed |
| US-9476045-B2 | iRNA agents with biocleavable tethers | ALNYLAM PHARMACEUTICALS, INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-20150073133-A1 | iRNA AGENTS WITH BIOCLEAVABLE TETHERS | BANK OF AMERICA, N.A. | 2015-03-12 | — | — | US | disclosed |
| US-8865677-B2 | iRNA agents with biocleavable tethers | ALNYLAM PHARMACEUTICALS, INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140179761-A1 | TARGETING LIPIDS | TEKMIRA PHARMACEUTICALS CORPORATION (CA) | 2014-06-26 | — | — | US | disclosed |
| US-20130281685-A1 | iRNA AGENTS WITH BIOCLEAVABLE TETHERS | BANK OF AMERICA, N.A. | 2013-10-24 | — | — | US | disclosed |
| US-8426377-B2 | iRNA agents with biocleavable tethers | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179761-A1 | TARGETING LIPIDS | LY96, ABHD10, APOB | LPAR1 4/4885LPAR3 16/4885LPAR2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.